Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

Published: August 2010
No. of Pages: 235
   

Report Summary

Vaccines have been one of the faster growing areas of the pharmaceutical industry, and during a troubling series of years, they have been the superstars of many companies' portfolios. They've also attracted the attention of insurance companies, retail outlets and the media. The global market for vaccines experienced strong growth through 2009 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions.

Kalorama Information has been closely following vaccine markets and since 2006 has instituted a yearly market research report schedule to keep up with fast-moving developments. Our latest comprehensive update, Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, examines the market for vaccines used in humans for various disease. This state-of-the-industry report is a must-have for any executive who wants to stay on top of a rapidly changing market and see what’s expected down the road. You can count on the objectivity and accuracy of our numbers and analysis—whether you're preparing a strategic presentation, benchmarking your company's performance against the competition, preparing a new product launch or seeking out an acquisition or a new partnership.

The report covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable.

Included in this report are current market size and forecast for the following vaccines:

  • Combinations
  • Hepatitis
  • HIB
  • MMR
  • Pneumococcal
  • Poliovirus
  • Varicella
  • Other Pediatric
  • Cervical Cancer
  • Hepatitis
  • Influenza
  • Pneumococcal
  • Travel; DT; Misc.

Important trends such as vaccine safety, vaccine shortages, preventing pandemics, vaccines and bioterrorism, DNA vaccination, innovations in vaccine delivery systems and innovations in vaccine Production are covered in the report. In addition, the reort profiles key competitors in the vaccine industry. Companies profiled in the report include:

  • AlphaVax, Inc.
  • Bavarian Nordic A/S
  • Baxter Healthcare
  • Bharat Biotech
  • Celldex Therapeutics
  • Crucell
  • Emergent biosolutions
  • GlaxoSmithKline
  • Medimmune
  • Merck & Co. Inc
  • Nabi Biopharmaceuticals
  • Novartis
  • Pfizer
  • Sanofi Pasteur

Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2005 to 2009 period and forecasts are provided through 2014. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis.

Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

Table Of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

The Global Vaccine Industry
Scope and Methodology
Overview
Pediatric Preventative Vaccines
The Market
Adult Preventative Vaccines
The Market
Total Market
Issues and Trends

CHAPTER TWO: INTRODUCTION TO VACCINES
A Brief History: The Development of Vaccines
The Immune Response
Mechanism of Action
Types of Vaccines
Attenuated (Weakened) Live Viruses
Killed (Inactivated) Viruses
Toxoid Vaccines
Genetically Engineered/Modified Vaccines
Subunit Vaccines
Conjugate Vaccines
DNA Vaccination
Vaccine Approval Process

CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES
Introduction
Childhood Immunization in the United States
Childhood Immunization Rates
Challenges to the Vaccine Delivery System
The Effect of U.S. Health Care Reform
Recommended Childhood Immunization Schedule
State Immunization Recommendations
United Nations Initiatives
Pediatric Vaccine Products
BCG
Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
Diphtheria
Pertussis
Tetanus
Hepatitis B
Poliomyelitis
Haemophilus Influenzae Type B
Hepatitis A
Measles, Mumps and Rubella
Measles
Mumps
Rubella
Meningococcal Disease
Pneumococcal Conjugate
Rotavirus
Varicella
Pediatric Vaccines in Development
Cost of Vaccines in the United States The World Market for Pediatric Preventive Vaccines
Total Market Size and Forecast
Hepatitis Vaccine Market
Market Analysis
Leading Products and Competitors
Haemophilus Influenzae Type B Vaccine Market
Market Analysis
Leading Products and Competitors
Measles, Mumps and Rubella Vaccines
Market Analysis
Combination Vaccines Market
Market Analysis
Leading Products and Competitors
Pneumococcal Vaccine
Leading Products and Competitors
Poliovirus Vaccine
Market Analysi
Leading Products and Competitors
Varicella Vaccine
Market Analysis
Leading Products and Competitors
Other Vaccines Market
Market Analysis
Leading Products and Competitors

CHAPTER FOUR: ADULT PREVENTIVE VACCINES
Introduction
Adult Vaccine-Preventable Diseases: Facts and Figures
Global Influenza Surveillance Program
Recommendations for Adult Immunizations
WHO International Health Regulations
Adult Vaccine Products
BCG
Cervical Cancer
Cholera
Diphtheria-Tetanus
Hepatitis
Hepatitis A
Hepatitis B
Influenza
Japanese Encephalitis
Pneumococcal Disease
Rabies
Shingles
Typhoid Fever
Yellow Fever
Adult Vaccines in Development
Total Market Size and Forecast
Cervical Cancer Market
Market Analysis
Leading Products and Competitors
Hepatitis Market
Market Analysis
Leading Products and Competitors
Influenza Vaccine Market
Market Analysis
Leading Products and Competitors
Market Analysis
Leading Products and Competitors
Travel, DT, and Miscellaneous Vaccine Market
Market Analysis
Leading Products and Competitors

CHAPTER FIVE: VACCINES MARKET SUMMARY

Trends Driving the Vaccines Market
Market Size and Forecast
Vaccine Sales by Region
Vaccine Market Competitors
Pediatric Vaccines
Major Manufacturer’s Market Share
Adult Vaccines
Major Manufacturer’s Market Share

CHAPTER SIX: ISSUES AND TRENDS
Vaccine Safety
Refusal to Immunize
Obesity
Post-Licensure Surveillance
Vaccine Adverse Event Reporting System
The Vaccine Safety Datalink Project
Phase IV studies
The Vaccine Injury Compensation Program
Countermeasures Injury Compensation Program
World Health Organization
Other Initiatives
The Future of Vaccine Safety
Vaccine Shortages
Preventing Shortages in the Developed Countries
Financial incentives
Equitable pricing
Vaccine stockpiles
Preventing Shortages in Developing Nations
Vaccine bonds
Preventing Pandemics
U.S. National Vaccine Plan
Vaccines and Bioterrorism
Overview
Project Bioshield Act
National Bio and Agro-Defense Facility
Vaccine Treatment and Evaluation Units
Anthrax
Smallpox
Tularemia
Viral Hemorrhagic Fevers
DNA Vaccination
Innovations in Vaccine Delivery Systems
Edible Vaccines
Mucosal Delivery
Intranasal Delivery
Vaccine Patches
Vaccine Chips
Innovations in Vaccine Production
Tobacco Plants
Insects
Nanoparticle Systems

CHAPTER SEVEN: COMPANY PROFILES
AlphaVax, Inc.
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Bavarian Nordic A/S
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Baxter Healthcare
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Bharat Biotech
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Celldex Therapeutics
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Crucell
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Emergent Biosolutions
History and Lines of Business
Strategic Acquisition and Alliance
Vaccine Products
Financial
GlaxoSmithKline
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Medimmune
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Merck & Co. Inc
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Nabi Biopharmaceuticals
History and Lines of Business
Strategic Alliance
Vaccine Products
Financial Information
Novartis
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information
Pfizer
History and Lines of Business
Strategic alliances
Vaccine Products
Financial Information
Sanofi Pasteur
History and Lines of Business
Strategic Alliances
Vaccine Products
Financial Information

APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Figure 1-1: World Market for Pediatric Vaccines 2005-2014 Revenues (in millions)
Figure 1-2: World Market for Adult Vaccines 2005-2014 Revenues (in millions)

CHAPTER TWO: INTRODUCTION TO VACCINES

Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2009
Table 2-2: Vaccine-Preventable Diseases, June 2010
Table 2-3: VAERS Table of Reportable Events Following Vaccination

CHAPTER THREE PEDIATRIC PREVENTIVE VACCINES
Table 3-1: Global Immunization Rates by Vaccine Type 2008
Table 3-2: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 2002-2008
Table 3-3 : U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years, 2010
Table 3-4: U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years, 2010
Table 3-5: Selected Pediatric Vaccines in Development, June 2010
Table 3-6 : World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combinations, Pneumococcal, Polio, Varicella, Others) 2005-2014 Revenues (in millions)
Figure 3-1: Market Share of Pediatric Vaccines by Type 2009
Figure 3-2: Market Share of Pediatric Vaccines, by Type 2014
Table 3-7 : World Market for Pediatric Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World) 2005-2014 Revenues (in millions)
Table 3-8: World Pediatric Hepatitis Vaccine Market 2005-2014 World Hib Vaccine Market, 2005-2014
Table 3-10: World MMR Vaccines Market 2005-2014
Table 3-11 World Combination Vaccines Market 2005-2014
Table 3-12 World Pediatric Pneumococcal Vaccine Market 2005-2014
Table 3-13 World Poliovirus Vaccine Market 2005-2014
Table 3-14 World Varicella Vaccine Market 2005-2014
Table 3-15 World Pediatric Other Vaccines Market 2005-2014

CHAPTER FOUR ADULT PREVENTIVE VACCINES
Table 4-1 Universal Adult Immunization Schedule 2010
Table 4-2 Adult Immunization Schedule for Populations with Special Medical Conditions, 2010
Table 4-3 Initiatives to Require HPV Vaccination by U.S. State, 2010
Table 4-4 WHO Pandemic Classification Schedule Selected Adult Preventive Vaccines in Development, 2010
Table 4-6 World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2005-2014 Revenues (in millions)
Figure 4-1 Market Share of Adult Vaccines, by Type, 2009
Figure 4-2 Market Share of Adult Vaccines, by Type, 2014
Table 4-7 World Market for Adult Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World) 2005-2014 Revenues (in millions)
Table 4-8 World Cervical CancerVaccine Market 2005-2014
Table 4-9 World Hepatitis Vaccine Market 2005-2014 World Influenza Vaccine Market 2005-2014
Table 4-11 CDC Goal to Double Flu Immunization by 2010 Group and Estimated Immunization Rate (2000 vs 2010)
Table 4-12 2009 Estimated Population by Region and Selected Age Group (in millions)
Table 4-13 World Pneumococcal Vaccine Market 2005-2014 World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2005-2014 160

CHAPTER FIVE VACCINES MARKET SUMMARY

Figure 5-1 Sales Growth of Vaccines vs. Pharmaceuticals 2005-2014
Figure 5-2 World Market for Vaccines by Type 2005-2014
Table 5-1 The World Vaccines Market by Vaccine Type 2005-2014 Revenues (in millions
Figure 5-3 World Market for Vaccines Share by Type, 2005, 2009 and 2014
Table 5-2 The World Vaccines Market by Region 2005-2014 Revenues (in millions)
Table 5-3 Major Manufacturers’ Shares of the World Vaccine Market, 2009
Figure 5-3 2009 World Vaccines Market Share, by Leading Competitors
Table 5-4 Major Manufacturer’s Shares of the World Pediatric Vaccine Market 2009
Figure 5-5 Market Share of Pediatric Vaccines Market, 2009
Table 5-5 Major Manufacturer’s Shares of the World Adult Vaccine Market 2009
Figure 5-6: Market Share of Adult Vaccines Market 2009

CHAPTER SIX ISSUES AND TRENDS
Table 6-1: Selected Companies/Laboratories Developing Biodefense Vaccines
Related Reports:
Emerging Cancer Vaccines: Forecasts, Developments and Pipeline Analysis, 4th Edition
Medical Research in China
Stakeholder Opinions: Sexually Transmitted Diseases - An underestimated threat lacking interventions to prevent transmission
Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of legal, productivity, and quality control issues
Cystic Fibrosis - Pipeline Assessment and Market Forecasts to 2017
Competitor Analysis: Tau and Amyloid Beta Targeted Therapy of Alzheimer’s Disease
Vaccines
Chronic Kidney Disease - Pipeline Assessment and Market Forecasts to 2016
South African Tuberculosis Vaccine Initiative (SATVI)-Detailed Product Pipeline
Poisoning Therapy Area Pipeline Report

Published By: Kalorama Information
Product Code: Kalorama Information1027


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100